Consolidated Statements of Cash Flows - USD ($)	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Net income (loss)	$ 698,000,000	$ 1,041,000,000	$ (82,000,000)
Adjustments to reconcile net income (loss) to cash provided by (used for) operating activities
Loss (gain) on disposal of businesses and assets	22,000,000	(78,000,000)	0
Depreciation and amortization	1,136,000,000	1,093,000,000	1,123,000,000
Deferred and prepaid income taxes	(63,000,000)	(124,000,000)	(82,000,000)
Stock-based compensation expense	220,000,000	194,000,000	170,000,000
Goodwill and other intangible asset impairment charges	132,000,000	370,000,000	533,000,000
Net loss (gain) on investments and notes receivable	1,000,000	(250,000,000)	(333,000,000)
Contingent consideration net expense (benefit)	35,000,000	(136,000,000)	(100,000,000)
Inventory step-up amortization	32,000,000	34,000,000	58,000,000
Debt extinguishment costs	194,000,000	0	0
Other, net	125,000,000	78,000,000	244,000,000
Increase (decrease) in operating assets and liabilities, excluding purchase accounting:
Trade accounts receivable	(220,000,000)	(279,000,000)	335,000,000
Inventories	(321,000,000)	(346,000,000)	(65,000,000)
Other assets	(209,000,000)	(134,000,000)	(265,000,000)
Accounts payable, accrued expenses and other liabilities	(255,000,000)	408,000,000	(28,000,000)
Cash provided by (used for) operating activities	1,526,000,000	1,870,000,000	1,508,000,000
Investing Activities
Purchases of property, plant and equipment and internal use software	(588,000,000)	(554,000,000)	(376,000,000)
Proceeds from sale of property, plant and equipment	12,000,000	14,000,000	12,000,000
Payments for acquisitions of businesses, net of cash acquired	(1,542,000,000)	(2,258,000,000)	(3,000,000)
Proceeds from disposal of certain businesses and assets	5,000,000	826,000,000	15,000,000
Proceeds from royalty rights	70,000,000	82,000,000	87,000,000
Proceeds from (payments for) settlements of hedge contracts	56,000,000	15,000,000	0
Proceeds from (payments for) investments and acquisitions of certain technologies	(24,000,000)	279,000,000	(146,000,000)
Cash provided by (used for) investing activities	(2,011,000,000)	(1,597,000,000)	(411,000,000)
Financing Activities
Payment of contingent consideration previously established in purchase accounting	(335,000,000)	(15,000,000)	(49,000,000)
Payments for royalty rights	(75,000,000)	(85,000,000)	(97,000,000)
Payments on short-term borrowings	(250,000,000)	0	(2,950,000,000)
Proceeds from short-term borrowings, net of debt issuance costs	0	0	2,245,000,000
Net increase (decrease) in commercial paper	(1,000,000)	0	(714,000,000)
Payments on borrowings from credit facilities	0	0	(1,919,000,000)
Proceeds from borrowings on credit facilities	0	0	1,916,000,000
Payments on long-term borrowings and debt extinguishment costs	(3,184,000,000)	0	(1,260,000,000)
Proceeds from long-term borrowings, net of debt issuance costs	3,270,000,000	0	1,683,000,000
Cash dividends paid on preferred stock	(55,000,000)	(55,000,000)	(28,000,000)
Net proceeds from issuance of preferred stock in connection with public offering	0	0	975,000,000
Net proceeds from issuance of common stock in connection with public offering	0	0	975,000,000
Payments for repurchase of common stock	0	0	(535,000,000)
Cash used to net share settle employee equity awards	(53,000,000)	(50,000,000)	(59,000,000)
Proceeds from issuances of shares of common stock pursuant to employee stock compensation and purchase plans	136,000,000	110,000,000	111,000,000
Cash provided by (used for) financing activities	(548,000,000)	(95,000,000)	293,000,000
Effect of foreign exchange rates on cash	(9,000,000)	(6,000,000)	(2,000,000)
Net increase (decrease) in cash, cash equivalents, restricted cash and restricted cash equivalents	(1,042,000,000)	173,000,000	1,388,000,000
Cash, cash equivalents, restricted cash and restricted cash equivalents at beginning of period	2,168,000,000	1,995,000,000	607,000,000
Cash, cash equivalents, restricted cash and restricted cash equivalents at end of period	1,126,000,000	2,168,000,000	1,995,000,000
Supplemental Information
Income Taxes Paid	662,000,000	302,000,000	207,000,000
Interest Paid, Excluding Capitalized Interest, Operating Activities	450,000,000	338,000,000	359,000,000
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Purchases	0	440,000,000	0
Non-cash impact of transferred royalty rights	$ (70,000,000)	$ (82,000,000)	$ (87,000,000)